From: Stereotactic body radiation therapy in the treatment of ovarian cancer
 | Local failure | Complete radiographic response | |
---|---|---|---|
Predictive factor | Univariate analysis (p value) | Hazard ratio (confidence interval) | Univariate analysis (p value) |
BED (Gy) | 0.016 | 0.95 (0.91–1.00) | 0.52 |
- BED ≤35 | 0.017 |  | 0.087 |
GTV | 0.22 | 1.04 (1.00–1.08) | 0.19 |
PTV | 0.62 | 0.98 (0.95–1.01) | 0.49 |
Target size | 0.16 | 1.04 (0.82–1.31) | 0.071 |
Treatment for recurrence | 0.029 | 0.71 (0.07–7.79) | 0.003 |
Treatment for lymph node | 0.34 | 0.36 (0.04–3.32) | 0.027 |
Treatment for liver metastasis | 0.025 | 0.20 (0.01–3.65) | 0.79 |
Time from primary diagnosis | 0.20 | 1.00 (0.99–1.02) | 0.49 |
Higher pre-treatment SUV | 0.026 | Â | 0.035 |